Drug Discovery Chemistry Will Be A Virtual Event For 2020

Like many of you, we have been closely following updates and evolving guidances from local, national and global agencies for COVID-19. There is still much uncertainty around the coronavirus, and how long our communities may be impacted by the pandemic, but it seems certain that decisions about how we work, travel and gather together will continue to be influenced for weeks and months still to come.

We have made the decision not to move forward with an in-person meeting for the Drug Discovery Chemistry conference this year. Instead, we are hard at work transitioning to a virtual event featuring online sessions, networking, exhibits and posters, running on the original August dates.

COVID-19 Updates & FAQ

About the Event

Cambridge Healthtech Institute's 15th Annual Drug Discovery Chemistry is a dynamic virtual conference for medicinal chemists working in pharma and biotech. Focused on discovery and optimization challenges of small molecule drug candidates, Drug Discovery Chemistry provides many exciting opportunities for scientists to create a unique program to hear presentations most suited to one's personal interests by going back and forth among concurrent conferences. The 2020 event includes new coverage of RNA as a small molecule target, expanded coverage of artificial intelligence for early drug discovery.



Maximize your educational and networking opportunities while in San Diego by adding on one or more interactive short courses! Covering some of the hottest topics in the field, these short courses are taught by leading researchers from industry and academia. Topics include the ubiquitin-proteasome system, immunology, pharmacology, FBDD, macrocyclics, phenotypic screening, PROTACs, GPCR structures, physical properties of drugs, DNA-encoded libraries, immuno-oncology, ligand-receptor interactions, and drug metabolism.